印度最高法院支持FSSAI禁止非医疗饮料使用“ORS”, India's top court backs FSSAI's ban on non-medical drinks using "ORS," citing public health risks.

德里高等法院维持印度FSSAI禁止非医用饮料使用“ORS”一词的禁令,裁定误导性标签对公共健康构成严重风险,商业利益不得压倒。 The Delhi High Court has upheld India's FSSAI ban on using the term "ORS" on non-medical beverages, ruling that misleading labels pose a serious public health risk and must not be overridden by commercial interests. 法院强调,只有符合世界卫生组织标准的产品才能合法地称为ORS, 并拒绝了Reddy博士的实验室关于出售现有股票的请求,尽管它允许该公司正式寻求FSSAI批准未出售的存货。 The court emphasized that only products meeting World Health Organization standards can legally be called ORS, and rejected Dr. Reddy's Laboratories' request to sell existing stock, though it allowed the company to formally seek FSSAI’s approval for unsold inventory. 该决定强化了金融监督署监管与健康有关的产品标签以防止消费者欺骗的权力。 The decision reinforces FSSAI’s authority to regulate health-related product labeling to prevent consumer deception. 有待作出详细判决。 A detailed judgment is pending.